Sino Biopharmaceutical Limited (HKG:1177)

Sino Biopharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	100,998	110,478	58,258	63,845	84,459	102,408
Market Cap Growth	50.92%	89.64%	-8.75%	-24.41%	-17.53%	-27.33%
Enterprise Value	106,032	115,449	64,462	66,382	90,167	114,126
Last Close Price	5.66	6.18	3.16	3.35	4.32	5.03
PE Ratio	39.19	42.37	15.64	24.85	29.37	5.71
Forward PE	19.59	21.62	17.48	17.77	20.63	12.33
PS Ratio	2.85	3.12	1.90	2.21	2.87	3.11
PB Ratio	2.16	2.36	1.28	1.52	1.97	2.21
P/TBV Ratio	3.36	3.68	1.78	1.96	2.59	2.84
P/FCF Ratio	11.27	12.33	9.68	11.60	14.88	22.84
P/OCF Ratio	9.77	10.69	8.28	9.55	11.93	15.55
PEG Ratio	0.98	0.84	1.24	1.34	-	0.62
EV/Sales Ratio	2.99	3.26	2.10	2.30	3.07	3.46
EV/EBITDA Ratio	13.27	14.30	8.79	9.45	12.75	17.05
EV/EBIT Ratio	15.52	16.49	10.44	11.08	14.81	20.07
EV/FCF Ratio	11.83	12.88	10.71	12.06	15.88	25.46
Debt / Equity Ratio	0.38	0.38	0.23	0.33	0.37	0.33
Debt / EBITDA Ratio	2.19	2.19	1.39	1.97	2.22	2.21
Debt / FCF Ratio	2.00	2.00	1.72	2.54	2.81	3.36
Net Debt / Equity Ratio	-0.16	-0.16	-0.12	-0.04	-0.07	-0.09
Net Debt / EBITDA Ratio	-0.95	-0.95	-0.74	-0.22	-0.45	-0.65
Net Debt / FCF Ratio	-0.86	-0.86	-0.90	-0.28	-0.56	-0.97
Asset Turnover	0.45	0.45	0.45	0.41	0.42	0.50
Inventory Turnover	2.47	2.47	2.44	2.31	2.10	2.79
Quick Ratio	1.23	1.23	1.11	0.90	1.15	1.38
Current Ratio	1.37	1.37	1.26	1.05	1.29	1.53
Return on Equity (ROE)	12.53%	12.53%	11.82%	12.12%	11.94%	55.25%
Return on Assets (ROA)	5.56%	5.56%	5.62%	5.33%	5.40%	5.37%
Return on Invested Capital (ROIC)	13.68%	13.22%	14.13%	12.90%	13.46%	15.24%
Return on Capital Employed (ROCE)	12.40%	12.40%	12.70%	13.30%	12.30%	10.30%
Earnings Yield	2.58%	2.36%	6.39%	4.02%	3.40%	17.51%
FCF Yield	8.87%	8.11%	10.33%	8.62%	6.72%	4.38%
Dividend Yield	1.84%	1.62%	2.22%	1.46%	2.78%	1.59%
Payout Ratio	64.12%	64.12%	52.76%	27.13%	49.84%	6.42%
Buyback Yield / Dilution	1.30%	1.30%	1.26%	2.57%	1.38%	-2.57%
Total Shareholder Return	3.14%	2.92%	3.48%	4.03%	4.16%	-0.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.